ArticleJournal of neuromuscular diseases2024

Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy.

Craig M Zaidman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.